Sanofi Beats on Q2 Earnings & Sales, Stock Down on Pipeline Setbacks
Sanofi SNY reported second-quarter 2026 adjusted earnings of $1.22 per American depositary share, which comfortably beat the Zacks…
Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026
Sanofi SNY reported fourth-quarter 2025 adjusted earnings of 89 cents per American depositary share, which beat the Zacks…
Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth
Sanofi SNY reported first-quarter 2026 adjusted earnings of $1.10 per American depositary share, which beat the Zacks Consensus…